These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22560380)

  • 21. Links between arterial and venous disease.
    Prandoni P
    J Intern Med; 2007 Sep; 262(3):341-50. PubMed ID: 17697155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pan-cardiovascular syndrome - venous thromboembolism and atherothrombotic vascular disease.
    Weiss N
    Vasa; 2010 Aug; 39(3):207-11. PubMed ID: 20845579
    [No Abstract]   [Full Text] [Related]  

  • 23. Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis.
    Rosendaal FR
    Thromb Haemost; 1997 Jul; 78(1):1-6. PubMed ID: 9198119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of atherosclerosis in children--the role of statins and aspirin].
    Stolarz-Skrzypek K; Bednarski A; Drozdz D; Czarnecka D
    Przegl Lek; 2013; 70(2):57-64. PubMed ID: 23879005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
    Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Management of the cardiology patient with polyvascular disease: PRISMA study].
    Cournot M; Cambou JP; Ferrières J; Grenier O; Herrmann MA; Cantet C; Leizorovicz A
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):841-8. PubMed ID: 15521475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atherosclerosis and venous thromboembolism - similarities.
    Undas A
    Kardiol Pol; 2013; 71(12):1223-8. PubMed ID: 24399581
    [No Abstract]   [Full Text] [Related]  

  • 28. Residual risk for secondary ischemic events in patients with atherothrombotic disease: opportunity for future improvements in patient care.
    Pepine CJ
    Ann Med; 2010; 42(1):19-35. PubMed ID: 20092398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atherothrombosis: management of patients at risk.
    Mas JL
    Int J Clin Pract; 2005 Apr; 59(4):407-14. PubMed ID: 15853855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Arterial bypass iterative thrombosis and cancer: three cases].
    Villemur B; Payraud E; Seetha V; De Angelis MP; Magne JL; Perennou D; Carpentier P; Pernod G
    J Mal Vasc; 2014 Feb; 39(1):14-7. PubMed ID: 24119420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of arterial thrombotic events in inflammatory bowel disease.
    Ha C; Magowan S; Accortt NA; Chen J; Stone CD
    Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.
    Folkeringa N; Coppens M; Veeger NJ; Bom VJ; Middeldorp S; Hamulyak K; Prins MH; Büller HR; van der Meer J
    Thromb Haemost; 2008 Jul; 100(1):38-44. PubMed ID: 18612536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study.
    Bova C; Marchiori A; Noto A; Rossi V; Daniele F; Santoro C; Ricchio R; De Lorenzo R; Umbaca R; Prandoni P
    Thromb Haemost; 2006 Aug; 96(2):132-6. PubMed ID: 16894454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A population-based study of an Italian genetic isolate reveals that mean platelet volume is not a risk factor for thrombosis.
    Biino G; Portas L; Murgia F; Vaccargiu S; Parracciani D; Pirastu M; Balduini CL
    Thromb Res; 2012 Apr; 129(4):e8-13. PubMed ID: 22137741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variants of tumor necrosis factor superfamily, member 4 (TNFSF4), and risk of incident atherothrombosis and venous thromboembolism.
    Mälarstig A; Eriksson P; Rose L; Diehl KA; Hamsten A; Ridker PM; Zee RY
    Clin Chem; 2008 May; 54(5):833-40. PubMed ID: 18356244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inherited thrombophilia in arterial disease: a selective review.
    de Moerloose P; Boehlen F
    Semin Hematol; 2007 Apr; 44(2):106-13. PubMed ID: 17433903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vascular disease and hormonal treatment--epidemiology].
    Vessey MP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism.
    Glynn RJ; Rosner B
    Am J Epidemiol; 2005 Nov; 162(10):975-82. PubMed ID: 16207808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.